Independent Advisor Alliance Has $4.78 Million Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Independent Advisor Alliance cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.3% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 9,720 shares of the medical equipment provider’s stock after selling 28 shares during the quarter. Independent Advisor Alliance’s holdings in Intuitive Surgical were worth $4,775,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of ISRG. Silvercrest Asset Management Group LLC boosted its position in Intuitive Surgical by 25.0% during the 1st quarter. Silvercrest Asset Management Group LLC now owns 60,339 shares of the medical equipment provider’s stock worth $24,081,000 after acquiring an additional 12,056 shares during the last quarter. Waverly Advisors LLC boosted its position in Intuitive Surgical by 27.1% during the 1st quarter. Waverly Advisors LLC now owns 2,552 shares of the medical equipment provider’s stock worth $1,018,000 after acquiring an additional 544 shares during the last quarter. Kennedy Capital Management LLC acquired a new position in Intuitive Surgical during the 1st quarter worth approximately $2,545,000. Janus Henderson Group PLC boosted its position in Intuitive Surgical by 11.0% during the 1st quarter. Janus Henderson Group PLC now owns 781,069 shares of the medical equipment provider’s stock worth $311,707,000 after acquiring an additional 77,107 shares during the last quarter. Finally, Connective Capital Management LLC acquired a new position in Intuitive Surgical during the 1st quarter worth approximately $9,274,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Intuitive Surgical

In related news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $482.21, for a total transaction of $90,655.48. Following the sale, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,655,048.26. This trade represents a 3.30 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, General Counsel Gary Loeb sold 300 shares of the firm’s stock in a transaction that occurred on Monday, September 9th. The shares were sold at an average price of $475.00, for a total transaction of $142,500.00. Following the completion of the sale, the general counsel now owns 1,595 shares in the company, valued at $757,625. This represents a 15.83 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 50,539 shares of company stock valued at $26,112,364. 0.80% of the stock is currently owned by company insiders.

Intuitive Surgical Trading Down 0.5 %

Shares of ISRG opened at $547.87 on Monday. Intuitive Surgical, Inc. has a 12 month low of $304.50 and a 12 month high of $552.00. The firm’s 50 day moving average is $504.73 and its 200-day moving average is $464.13. The stock has a market capitalization of $195.14 billion, a PE ratio of 88.08, a P/E/G ratio of 5.39 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion for the quarter, compared to analysts’ expectations of $2.01 billion. Equities research analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. Raymond James increased their price objective on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. BTIG Research set a $535.00 target price on shares of Intuitive Surgical in a report on Friday, October 18th. Robert W. Baird upped their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Finally, Stifel Nicolaus upped their target price on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. One analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $524.61.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.